Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 17, 2023

SELL
$41.75 - $54.5 $303,188 - $395,779
-7,262 Reduced 0.89%
805,728 $41.3 Million
Q3 2022

Oct 24, 2022

SELL
$43.76 - $53.42 $518,468 - $632,920
-11,848 Reduced 1.44%
812,990 $35.6 Million
Q2 2022

Jul 21, 2022

SELL
$46.53 - $55.17 $643,556 - $763,056
-13,831 Reduced 1.65%
824,838 $43.2 Million
Q1 2022

Apr 27, 2022

SELL
$45.75 - $56.69 $81,892 - $101,475
-1,790 Reduced 0.21%
838,669 $43.4 Million
Q4 2021

Jan 20, 2022

SELL
$41.32 - $61.25 $346,840 - $514,132
-8,394 Reduced 0.99%
840,459 $49.6 Million
Q3 2021

Oct 22, 2021

SELL
$39.25 - $50.42 $832,728 - $1.07 Million
-21,216 Reduced 2.44%
848,853 $36.5 Million
Q2 2021

Jul 20, 2021

SELL
$35.91 - $40.68 $328,612 - $372,262
-9,151 Reduced 1.04%
870,069 $34.1 Million
Q1 2021

Apr 16, 2021

BUY
$33.49 - $37.77 $9.39 Million - $10.6 Million
280,496 Added 46.85%
879,220 $31.9 Million
Q4 2020

Jan 20, 2021

BUY
$33.47 - $42.56 $131,537 - $167,260
3,930 Added 0.66%
598,724 $22 Million
Q3 2020

Oct 23, 2020

BUY
$31.75 - $37.25 $18.6 Million - $21.8 Million
586,575 Added 7136.82%
594,794 $21.8 Million
Q2 2020

Jul 15, 2020

SELL
$30.12 - $36.54 $2,921 - $3,544
-97 Reduced 1.17%
8,219 $269,000
Q1 2020

Apr 27, 2020

BUY
$27.03 - $38.62 $63,006 - $90,023
2,331 Added 38.95%
8,316 $271,000
Q4 2019

Jan 23, 2020

BUY
$32.92 - $37.36 $197,026 - $223,599
5,985 New
5,985 $234,000
Q3 2019

Oct 23, 2019

SELL
$32.49 - $42.13 $162,514 - $210,734
-5,002 Closed
0 $0
Q2 2019

Aug 05, 2019

BUY
$36.98 - $41.52 $184,973 - $207,683
5,002 New
5,002 $217,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ami Asset Management Corp Portfolio

Follow Ami Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ami Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Ami Asset Management Corp with notifications on news.